Advanced Clinical Research Institute

Advanced Clinical Research Institute (ACRI) is a specialized clinical research site and contract research organization (CRO) based in Anaheim, California, that focuses on Phase I-IV clinical trials. Historically operating as the clinical arm of WCCT Global, ACRI is widely recognized for its expertise in early-phase drug development, including first-in-human studies and complex clinical protocols. The institute is particularly noted for its leadership in ethnobridging studies, facilitating the development of global clinical data by recruiting diverse populations, including specific Asian cohorts. In 2021, ACRI and its parent company WCCT Global were acquired by Altasciences, a leading integrated drug development solution provider, to serve as a key clinical hub on the U.S. West Coast.